1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. Camfield PR, Camfield CS. Pediatric epilepsy: an overview. 2012. Elvesier. 703-710. Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A. Cross HJ et al. A practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482. Resnick T, Sheth RD. Early diagnosis and treatment of Lennox-Gastaut syndrome. Journal of Child Neurology. 2017;1-7. Gamayani U, Panggabean R. Epilepsi. 2015. Pustaka Cendekia Press. 225-242. Asadi Pooya AA. Lennox-Gastaut syndrome: comprehensive review. Neuro Sci. 2018;39:403-414. Arzimanoglou A, French J, Blume WT, Corss HJ, Ernst JP et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8:82-93. Asadi-Pooya AA, Sharifzade M. Lennox gastaut syndrome in south Iran: electro-clinical manifestation. Seizure. 2012; 21910):760-763. Trevathan E. Infantile spasm and lennox gastaut syndrome. Journal of Child Neurology. 2002;17:2S9-2S22. Carmant L, Whiting S. Lennox-Gastaut syndrome: an update on treatment. Can J Neurol Sci. 2012;39:702-711. Gallop K, Wild D, Nixon A, Verdian L, Cramer JA. Impact of Lennox-Gastaut syndrome on health-related quality of life of patient and caregivers: literature review. Seizure. 2009;18:554-558. Mastrangelo M. Lennox-Gastaut: a state of the review. Neuropediatrics; 2017. Donat JF. The age-dependent epileptic encephalopathies. J Child Neurol. 1992;7:7-21. Saleh TA, Stephen L. Lennox-Gastaut syndrome, review of the literature and a case report. Head Face Med. 2008;4(1):1-7. Camfield PR. Definition and natural history of Lennox-Gastaut syndrome. Epilepsia. 2011;52(Suppl 5):3-9. Ohtahara S, YaPmatogi Y, Ohtsuka Y. Prognosis of the lennox syndrome-long term clinical and electroencephalographic follow-up study, especially with special reference to relationship with the west syndrome. Folia Psychiatr Neurol Japan. 1976;30(3):275-87. Widdes-Walsh P, Dlugos D, Fahlstrom R, Joshi S, Shellhaas R. Boro A et al. LennoxGastaut syndrome of unkonwn cause: phenotypic characteristics of patients in the epilepsy. Epilepsy Behav. 2013;54(11):1898-904. Selmer KK, Lund C, Brandal K, Undlien DE, Brodtkorb E. SCN1A mutation screening in adult patients with Lennox–Gastaut syndrome features. Epilepsy Behav. 2009; 16(3):555– 557 von Spiczak S, Helbig KL, Shinde DN, Huether R, Pendziwiat M, et al. DNM1 encephalopathy: a new disease of vesicle fission. Neurology. 2017; 89(4):385–394. Lund C, Brodtkorb E, Øye AM, Røsby O, Selmer KK. CHD2 mutations in Lennox-Gastaut syndrome. Epilepsy Behav. 2014;33:18–21. Intusoma U, Abbott DF, Masterton RA, Stagnitti MR, Newton MR, Jackson GD et al. Tonic seizures of Lennox-Gastaut syndrome: periictal single-photon emission computed tomography suggests a corticopontine network. Epilepsia. 2013; 54(12):2151–2157. Bare MA, Glauser TA, Strawsburg RH. Need for electroencephalogram video confirmation of atypical absence seizures in children with Lennox-Gastaut syndrome. J Child Neurol. 1998;13(10):498–500. 22. Chevrie JJ, Aicardi J. Childhood epileptic encephalopathy with slow spike-wave. A statistical study of 80 cases. Epilepsia. 1972; 13: 259–71. 23. Arzimanoglou A, Guerrini R, Aicardi J. Lennox-Gastaut syndrome In: Aicardi’s epilepsy in children. Philadelphia: Lippincott Williams & Wilkins, 2004: 38–50. 24. Archer JS, Warren AE, Jackson GD, Abbott DF: Conceptualizing Lennox-Gastaut syndrome as a secondary network epilepsy. Front Neurol. 2015; 5:225. 25. Dupont S, Wolters RB, An-Gourfinkel I, Lambrecq V, Navarro V et al. Understandimg Lennox-Gastaut syndrome: insight from focal epilepsy patients with Lennox-Gastaut features. J Neuro. 2017. 26. Bourgeois BF, Douglas LM, Sankar R. Lennox-Gastaut syndrome: a consensus approach to differential diagnosis. Epilepsia. 2014;55(Suppl.4): 4-9. 27. Hoffmann-Riem M, Diener W, Benninger C, et al. Nonconvulsive status epilepticus–a possible cause of mental retardation in patients with Lennox-Gastaut syndrome. Neuropediatrics. 2000;31:169–174. 28. Blume WT. Lennox–Gastaut syndrome: potential mechanisms of cognitive regression. Ment Retard Dev Disabil Res Rev. 2004;10(2):150–153. 29. Pedersen M, Curwood EK, Archer JS, Abbott DF, Jackson GD. Brain regions with abnormal network properties in severe epilepsy of Lennox–Gastaut phenotype: multivariate analysis of task-free fMRI. Epilepsia. 2015;56(11):1767–1773. 30. Autry AR, Trevathan E, Van Naarden BK, Yeargin-Allsopp M. Increased risk of death among children with Lennox-Gastaut syndrome and infantile spasms. J Child Neurol. 2010;25 (4):441-447. 31. Arzimanoglou A, Resnick T. All children who experience epileptic falls do not necessarily have Lennox-Gastaut syndrome but many do. Epileptic Disord. 2011;13(suppl 1):S3-S13. 32. Markand ON. Lennox-Gastaut syndrome (childhood epileptic encephalopathy). J Clin Neurophysiol. 2003;20:426-441. 33. Kothare SV. Trevathan E. Sudden death risk among children with epilepsy. Neurology. 2018;91(2): 57-58. 34. Micholaus A, Farell K. Medical management of Lennox-Gastaut syndrome. CNS Drug. 2010;24(5):363-74. 35. Motte J, Trevathan E, Arvidsson JF, Barera MN, Mullens EL et al. Lamotrigine for generalized seizure associated with the Lennox-Gastaut syndrome. Engl J Med. 1997:18;337(25):1807-12. 36. Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology. 2008;20;70(21):1950-8. 37. Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med. 1993;07;328(1)29-33. 38. Jaraba S, Santamarina E, Miró J, Toledo M, Molins A, Burcet J, Becerra JL, Raspall M, Pico G, Miravet E, Cano A, Fossas P, Fernández S, Falip M. Rufinamide in children and adults in routine clinical practice. Acta Neurol Scand. 2017 Jan;135(1):122-128. 39. Wheless JW, Isojarvi J, Lee D, Drummond R, Benbadis SR. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience. Epilepsy Behav. 2014 Dec;41:47-52. 40. Kim EH, Ko TS. Cognitive impairment in childhood onset epilepsy: up-to-date information about its causes. Korean J Pediatr. 2016;59(40):155-164. 41. Yamatogi Y, Ohtsuka Y, Ishida T, et al: Treatment of the Lennox syndrome with ACTH: A clinical and electroencephalographic study. Brain Dev 1979;1:267–276. 42. vitevva E. Basic cellular and molecular mechanisms of refractory epilepsy: a review of current hypotheses. Mol Cell Epilepsy. 2014;1(1):7-12. 43. Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy (Review). Cochrane Database of Systemic Reviews 2016, Issue 2. Art. No: CD001903. 44. Henderson CB, Filloux FM, Alder SC, Lylon JL, Caplin DA. Efficacy of the ketogenic diet as a treatment option for epilepsy: meta analysis. J Child Neurol. 2006;21(3):193-8. 45. Keene DL. A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol. 2006;35(1):1-5. 46. Fitzsimmons G, Sewell M. Ketogenic diets. Dalam: Shaw V, penyunting. Clinical Paediatric Dietetics. Edisi ke 4. Wiley Blackwell, United Kingdom; 2015.p.354-80. 47. de Lima PA, de Brito Sampaio LP, Damasceno NRT. Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy. Clinics. 2014;69(10):699-705. 48. Gano B, Patel M, Rho JM. Ketogenic diets, mitochondria and neurological disease. J Lipid Res. 2014;55:2211-28. 49. Bergvist AGC. Indications and contraindications of the ketogenic diet. Dalam: Stafstrom CE, Rho JM, editor. Dalam: Epilepsy and the ketogenic diet. Humana Press Inc. Totowa, New Jersey. 2004.p.111-21. 50. Felton EA, Cervenka MC. Dietary therapy is the best option for refractory non surgical epilepsy. Epilepsia. 2015;56(9):1325-9. 51. Misiewicz RA. So TY. The use of ketogenic diet in pediatric patients with epilepsy. ISRN Pediatr. 2012;2012:1-10. 52. Groesback DK, Bluml RM, Kossof EH. Long-term use of the ketigenic diet in the treatment of epilepsy. Dev Med Child Neurol. 2006;48(12):978-981. 53. Batubara JR, Tjahjono HA, Aditiawati. Panduan praktik klinis Ikatan dokter anak Indonesia perawakan pendek ada anak dan remaja di Indonesia. Jakarta. UKK Endokrinologi IDAI. 2017.p.1-6.